EMEA-001877-PIP01-15-M02
Key facts
Invented name |
Ajovy
|
Active substance |
fremanezumab
|
Therapeutic area |
Neurology
|
Decision number |
P/0411/2019
|
PIP number |
EMEA-001877-PIP01-15-M02
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Prevention of migraine headaches
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Teva GmbH
Tel. +41 552201546 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|